EIF4E and depressive symptom measurement: To further address the underlying mechanisms of eIF4E phosphorylation in the etiology of depression, we showed that eFT508 treatment significantly rescued LPS-induced depressive-like behaviors, neuroinflammation, and synaptic protein dysregulations in the mice.